4.5 Article

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: A serological study within a randomised trial of different measles vaccines

期刊

VACCINE
卷 31, 期 48, 页码 5766-5771

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2013.08.044

关键词

Antibody response; Edmonston-Zagreb measles vaccine; Non-specific effects of vaccines; Schwarz measles vaccine; Two-dose measles vaccination

资金

  1. Danish Council for Development Research
  2. EU FP7 programme (OPTIMUNIZE)
  3. ERC Starting Grant [ERC-2009-StG-243149]
  4. Novo Nordisk Foundation
  5. Danish National Research Foundation

向作者/读者索取更多资源

Standard-titre Schwarz (SW) and Edmonston-Zagreb (EZ) measles vaccines (MV) are both used in the routine immunisation programme. Within a trial of different strains of MV, we examined antibody responses in both one-dose and two-dose schedules when the first dose was administered at 9 months. Setting and Methods: The trial was conducted in an urban area in Guinea-Bissau where we have had a health and demographic surveillance system and studied strategies to prevent measles infection since 1978. In the present study, children were randomised to SW or EZ as the first MV and furthermore randomised to a second dose of the same MV or no vaccine at 18 months of age. We obtained blood samples from 996 children at baseline; post-vaccination blood samples were collected at 18 and 24 months of age to assess measles antibody levels after one or two doses of MV. Results: At age 18 months all had responded to the first dose and only 1% (8/699) of the children had non-protective antibody levels irrespective of vaccine type. SW was associated with significantly higher levels of measles antibodies (geometric mean titre (GMT) = 2114 mIU/mL (95%CI 1153-2412)) than EZ (GMT = 807 mIU/mL (722-908)) (p = 0.001). Antibody concentration was significantly higher in girls than in boys after EZ but not after SW. Antibody levels were higher in the rainy than the dry season. There was no clear indication that a booster dose at 18 months increased the antibody level at 24 months of age. Conclusions: Maternal antibody levels have declined significantly in recent years and 99% had protective levels of measles antibody following primary MV at 9 months of age. It is unlikely that measles prevention and child health will be improved by increasing the age of MV as currently recommended. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据